Cel-Sci
CVM
#9766
Rank
S$66.84 M
Marketcap
S$8.36
Share price
2.54%
Change (1 day)
-62.81%
Change (1 year)

Cel-Sci (CVM) - Net assets

Net assets on the balance sheet as of June 2025 : S$9.1 Million

According to Cel-Sci 's latest financial reports the company has S$9.1 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cel-Sci - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$S$16.53 M-8.41%
2023-09-30$S$18.05 M-60.9%
2022-09-30$S$46.16 M-39.88%
2021-09-30$S$76.78 M185.23%
2020-09-30$S$26.92 M279.4%
2019-09-30$S$7.09 M566439.01%
2018-09-30$S$0 M-100.03%
2017-09-30$-S$4.54 Million389.43%
2016-09-30$-S$0.93 Million-86.33%
2015-09-30$-S$6.78 Million-150.88%
2014-09-30$S$13.32 M58.45%
2013-09-30$S$8.4 M-2.63%
2012-09-30$S$8.63 M-26.76%
2011-09-30$S$11.79 M-67.82%
2010-09-30$S$36.64 M192.77%
2009-09-30$S$12.51 M-19.63%
2008-09-30$S$15.57 M-28.11%
2007-09-30$S$21.65 M-1565.53%
2006-09-30$-S$1.48 Million-141.54%
2005-09-30$S$3.55 M-48.65%
2004-09-30$S$6.92 M227.18%
2003-09-30$S$2.11 M12.16%
2002-09-30$S$1.88 M-73.27%
2001-09-30$S$7.06 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Curis
CRIS
-S$19.05 Million-309.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.51 Billion-5,621.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.47 B 136,826.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.81 B 8,801.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$9.40 B 103,160.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$102.77 B 1,128,407.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.75 B 8,191.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$4.62 M-49.18%๐Ÿ‡บ๐Ÿ‡ธ USA